Investigation of the molecular and genetic mechanisms promoting oral cancer development and progression

Study ID: 8130
Short Title: Head and Neck Cancer: molecular, cellular and immunological mechanisms
Trust Name: UHD,UHS
Recruitment Site: Poole Hospital,Southampton General Hospital
Disease Area: Head and neck cancer
Phase: N/A
Expected End Date: 20/03/2025
Postcode: SO16 6YD
BH15 2JB
Contact Name: Amanda Pattie
Contact Email: studysupport1and3.crnwessex@nihr.ac.uk
Active: Yes

Inclusion criteria, exclusion criteria and study summary

- Clinical suspicion of premalignant oral/oropharyngeal/laryngeal lesion and/or condition. - Clinical and histopathologic diagnosis of oral/oropharyngeal/laryngeal cancer.

N/A

Oral cancer (OSCC) is the 8th most common cancer worldwide, representing about 4% of all malignancies. In the UK, the incidence has increased dramatically over the last 20 years, particularly in young non-smokers, with around 5,000 new cases each year. Compared with many cancers, OSCC remains a relatively understudied disease. And despite advances in surgery and radiotherapy, which remain the standard treatment options, the mortality rate has remained unchanged for decades, with a 5-year survival rate of around 50%. Oral cancer may be preceded by a premalignant, histologically dysplastic lesion, usually presenting clinically as a white or red patch in the mouth. However, only around 10-15% of patients diagnosed with oral dysplasia will develop oral cancer.

Study MapList of studies

Accessibility tools

Return to header